Growth hormone-releasing peptide (GHRP)

Cellular and Molecular Life Sciences

Volumn 54, Issue 12, 1998, Pages 1316-1329

  Bowers, C Y ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

GHRH; GHRP; Growth hormone; Hypothalamus; Pituitary; SRIF; U factor

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; SYNTHETIC PEPTIDE;

CONTROLLED STUDY; GROWTH HORMONE RELEASE; HUMAN; HYPOPHYSIS; HYPOTHALAMUS; NONHUMAN; PHYSIOLOGY; RAT; REVIEW;

ANIMALS; HUMANS; HYPOTHALAMUS; OLIGOPEPTIDES; PITUITARY GLAND;

ANIMALIA;

EID: 0032444392     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000180050257     Document Type: Review

References (62)

1. Conn P. M. and Bowers C. Y. (1996) A new receptor for growth hormone-release peptide. Science 273: 923
2. Bowers C. Y., Chang J. K. and Fong T. T. W. (1977) A synthetic pentapeptide which specifically releases GH, in vitro. In: Program Endocrine Society, 59th Annual Meeting, Chicago, p. 2332
3. Bowers C. Y., Reynolds G. A., Chang D., Hong A., Chang K. and Momany F. (1981) A study on the regulation of GH release from the pituitary of rats, in vitro. Endocrinology 108: 1071-1079
4. Bowers C. Y., Folkers K., Sievertsson H., Chang J. K., Currie B. L. and Bogentoft C. (1971) Synthetic peptides that release TSH and LH from the pituitary. In: Endocrinology 1971. Proceedings of the Third International Symposium, pp. 192-210. William Heinemann Medical Books Ltd., London
5. 2 (decapeptide), its analogs and other small peptides. In: Hypothalamic Hypophysiotropic Hormones: Physiological and Clinical Studies, pp. 68-88, Gual C. and Rosemberg E. (eds). Excerpta Medica Foundation, Amsterdam
6. Bowers C. Y., Momany F., Chang D., Hong A. and Chang K. (1981) Structure-activity relationships of a synthetic pentapeptide that specifically releases GH in vitro. Endocrinology 106: 663-667
7. Momany F. A., Bowers C. Y., Reynolds G. A., Chung D., Hong A. and Newlander K. (1981) Design, synthesis and biological activity of peptides which release growth hormone in vitro. Endocrinology 108: 31-39
8. Momany F., Bowers C. Y., Reynolds G. A., Hong A. and Newlander K. (1984) Conformational energy studies and in vitro activity data on active GH releasing peptides. Endocrinology 114: 1531-1536
9. Bowers C. Y., Momany F., Reynolds G. A. and Hong A. (1984) On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone. Endocrinology 114: 1537-1545
10. Bowers C. Y., Momany F. and Reynolds G. A. (1982) In vitro and in vivo activity of a small synthetic peptide with potent GH releasing activity. In: Program Endocrine Society, 64th Annual Meeting, San Francisco, p. 205
11. Bowers C. Y., Momany F., Renolds G. A. and Sartor O. (1984) Multiple receptors mediate GH release. Seventh International Congress of Endocrinology, Quebec, Canada, p. 464
12. Codd E. E., Shu A. Y. I., and Walker R. F. (1989) Binding of a growth hormone releasing hexapeptide to specific hypothalamic and pituitary sites. Neuropharmacology 28: 1139-1144
13. Sethumadhavan K., Veeraragavan K. and Bowers C. Y. (1991) Demonstration and characterization of the specific binding of growth hormone releasing peptide (GHRP) to rat anterior pituitary and hypothalamic membranes. Biochem. Biophys. Res. Commun. 178: 31-37
14. Veeraragavan K., Sethumadhavan K. and Bowers C. Y. (1992) Growth hormone-releasing peptide (GHRP) binding to porcine anterior pituitary and hypothalamic membranes. Life Sci. 50: 1149-1155
15. Bowers C. Y., Sartor A. O., Reynolds G. A. and Badger T. M. (1991) On the action of the growth hormone releasing hexapeptide GHRP. Endocrinology 128: 2027-2035
16. Bowers C. Y., Veeraragavan K. and Sethumadhavan K. (1994) Atypical growth hormone releasing peptides. In: Growth Hormone II: Basic and Clinical Aspects, pp. 203-222, Bercu B. and Walker R. (eds), Springer, New York
17. Bowers C. Y. (1996) Xenobiotic growth hormone secretagogues. In: Growth Hormone Secretagogues, pp. 9-28, Bercu B. and Walker R. (eds), Springer, New York
18. Bowers C. Y. (1998) GHRP + GHRH synergistic release of GH: scope and implication. In: Growth Hormone Secretagogues, pp. 1-25, Bercu B. and Walker R. (eds), Marcel Dekker, New York
19. Pandya N, Demott-Friberg R., Bowers C. Y., Barkan A. L. and Jaffe C. A. (1998) Growth hormone (GH)-releasing peptide-6 requires endogenous hypothalamic GH-releasing hormone for maximal GH stimulation. J. Clin. Endocrinol. Metab. 83: 1186-1189
20. Dickson S. L., Leng G. and Robinson I. C. A. F. (1993) Systemic administration of growth hormone releasing peptide activates hypothalamic arcuate neurons. Neuroscience 53: 303-306
21. Dickson S. L. (1994) Evidence for a central site and mechanism of action of growth hormone releasing peptide (GHRP-6). In: Growth Hormone II: Basic and Clinical Aspects, pp. 237-251, Bercu B. and Walker R. (eds), Springer, New York
22. Dickson S. L., Doutrelant-Viltart O., McKenzie D. N. and Dyball R. E. J. (1996) Growth hormone releasing peptide activates rat arcuate neurons recorded in vitro. Tenth International Congress of Endocrinology, p. 286
23. Dickson S. L., Doutrelant-Viltart O. and Leng G. (1995) Growth hormone (GH) deficient dw dw rats and lit lit mice show increased fos expression in the hypothalamic arcuate nucleus following systemic injection of GH-releasing peptide (GHRP-6). J. Endocrinol. 146: 519-526
24. Dickson S. L. and Luckman S. M. (1997) Induction of cfos messenger ribonucleic acid in neuropeptide Y and growth hormone (GH)-releasing factor neurons in the rat arcuate nucleus following systemic injection of the GH secregogue. GH-releasing peptide-6. Endocrinology 138: 771-777
25. Kamegai J., Hasegawa O., Minami S., Sugihara H. and Wakabayashi I. (1996) The growth hormone releasing peptide KP-102 induces cfos expression in the arcuate nucleus. Mol. Brain Res. 39: 153-159
26. Dickson S., Viltart O., Bailey A. R. T. and Leng G. (1997) Attentuation of the growth hormone secretagogue induction of fos protein in the rat arcuate nucleus by central somatostatin action. Neuroendocrinology 66: 188-194
27. Guillaume V., Magnan E., Cataldi M., Dutour A., Sauze N., Renard M. et al. (1994) Growth hormone (GH)-releasing hormone secretion is stimulated by a new GH-releasing hexapeptide in sheep. Endocrinology 135: 1073-1075
28. Smith R. G., Van der Ploeg L. H., Howard A. D., Feighner S. D., Cheng K., Hickey G. J. et al. (1997) Peptidomimetic regulation of growth hormone secretion. Endocr. Rev. 18: 621-645
29. Howard A. D., Feighner S. D., Cully D. F., Arena J. P., Liberator P. A., Rosenblum C. I. et al. (1996) A receptor in pituitary and hypothalamus and functions in growth hormone release. Science 273: 974-977
30. Feighner S. D., Howard A. D., Prendergast K., Palyha O. C., Hreniuk D. L., Nargund R. et al. (1998) Structural requirements for the activation of the human growth hormone secretagogue receptor by peptide and nonpeptide secretagogues. Mol. Endocrinol. 12: 137-145
31. Bennett P. A., Thomas G. B., Howard A. D., Van der Ploeg L. H. T., Smith R. G. and Robinson I. C. A. F. (1997) Expression and regulation of the growth hormone secretagogue-receptor (GHS-R) gene in normal and dwarf rats. Endocrinology 138: 4552-4557
32. Guan X.-M., Yu H., Palyha O. C., McKee K. K., Feighner S. D., Sirinathsinghji D. J. S. et al. (1997) Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues. Mol. Brain Res. 48: 23-29
33. Ong H., McNicoll N., Escher E., Collu R., Deghenghi R., Locatelli V. et al. (1998) Identification of a pituitary growth hormone-releasing peptide (GHRP) receptor suptype by photoaffinity labeling. Endocrinology 139: 432-435
34. 3 cells. J. Clin. Endocrinol. Metab. 83: 638-642
35. Korbonits M., Aylwin S. J. B., Trainer P. J., Burrin J. M., Besser G. M. and Grossman A. B. (1997) Growth hormone secretagogue-receptor mRNA is expressed in human pituitaty adenoma tissue. In: Program Endocrine Society, 79th Annual Meeting, p. 128
36. Shimon I., Yan X. and Melmed S. (1998) Human fetal pituitary expresses functional growth hormone-releasing peptide receptors. J. Clin. Endocrinol. Metab. 83: 174-178
37. Bowers C. Y. (1998) GH releasing peptide (GHRPs). In: Handbook of Physiology, Kostyo J. (ed.), Oxford University Press, Cary, in press
38. Bowers C. Y. (1998) GHRP historical perspective: basic and clinical. In: Human Growth Hormone: Basic and Clinical Research, Contemporary Endocrinology, Smith R. and Conn M. (eds), Humana Press, New York, in press
39. Bowers CY. (1998) GHRP-GH secretagogues. In: Endocrine Update Series, Bengtsson B. A. (ed.), Kluwer, Norwell, in press
40. Bowers C. Y., Reynolds G. A., Durham D., Barrera C. M., Pezzoli S. S. and Thorner M. O. (1990) Growth hormone releasing peptide stimulates GH release in normal men and acts synergistically with GH-releasing hormone. J. Clin. Endocrinol. Metab. 70: 975-982
41. Ilson B. E., Jorkasky D. K., Curnow R. T. and Stote R. M. (1989) Effect of a new synthetic hexapeptide to selectively stimulate growth hormone release in healthy human subjects. J. Clin. Endocrinol. Metab. 69: 212-214
42. Huhn W. C., Hartman M. L., Pezzoli S. S. and Thorner M. O. (1993) 24-h growth hormone (GH)-releasing peptide (GHRP) infusion enhances pulsatile GH secretion and specifically attenuates the response to a subsequent GHRP bolus. J. Clin. Endocrinol. Metab. 76: 1201-1208
43. Jaffe C. A., Ho J., Demott-Friberg R., Bowers C. Y. and Barkan A. L. (1993) Effects of a prolonged growth hormone (GH)-releasing peptide infusion on pulsatile GH secretion in normal men. J. Clin. Endocrinol. Metab. 77: 1641-1647
44. Clark R. G., Carlsson L. M. S., Trohnar J. and Robinson I. C. A. F. (1989) The effects of a growth hormone releasing peptide and growth hormone releasing factor in conscious and anesthetized rats. J. Neuroendocrinol. 1: 249-255
45. Patchett A. A., Nargund R. P., Tata J. R., Chen M. H., Barakat K. G., Johnston D. B. R. et al. (1995) Design and biological activities of L-163-191 (MK-0677): a potent, orally active growth hormone secretagogue. Proc. Natl. Acad. Sci. USA 92: 7001-7005
46. Smith R. G., Pong S. S., Hickey G., Jacks T., Cheng K. and Leonard R. (1996) Modulation of pulsatile GH release through a novel receptor in hypothalamus and pituitary gland. Recent Prog. Horm. Res. 51: 261-286
47. Bowers C. Y., Reynolds G. A., Kaf-Alghazal A., Albustamy A., Almasri A., Lopez A. et al. (1997) Indirect evidence for the existence of an endogenous putative GHRP hormone. In: Program Endocrine Society, 79th Annual Meeting, p. 333
48. Massoud A. F., Hindmarsh P. C. and Brook C. G. D. (1997) Interaction of the growth hormone releasing peptide hexarelin with somatostatin. Clin. Endocrinol. 47: 537-547
49. Klinger B., Silbergeld A., Deghenghi R., Frenkel J. and Laron Z. (1996) Desensitization from long-term intranasal treatment with hexarelin does not interfere with the biological effects of this growth hormone releasing peptide in short chidren. Eur. J. Endocrinol. 134: 716-719
50. Pihoker C., Badger T. M., Reynolds G. A. and Bowers C. Y. (1997) Treatment effects of intranasal growth hormone releasing peptide-2 in children with short stature. J. Endocrinol. 155: 79-86
51. Mericq V., Salazar T., Avila A., Inguez G., Bowers C. Y., Cassorla F. et al. (1998) Treatment with growth hormone releasing peptide accelerates growth of growth hormone-deficient children. J. Clin. Endocrinol. Metab. 83: 2355-2360
52. Laron Z., Bowers C. Y., Hirsch D., Almonte A. S., Pelz M., Keret R. et al. (1993) Growth hormone releasing activity of growth hormone releasing peptide-1 (a synthetic heptapeptide) in children and adolescents. Acta Endocrinol. 129: 424-426
53. Mericq V., Cassorla F., Garcia H., Avila A., Bowers C. Y. and Merriam G. (1995) Growth hormone responses to growth hormone releasing peptide (GHRP) and to growth hormone releasing hormone (GHRH) in growth hormone deficient children (GHD). J. Clin. Endocrinol. Metab. 80: 1681-1684
54. 2) in children with GH insufficiency and idiopathic short stature. Metabolism 44: 1199-1204
55. Pihoker C., Middleton R., Reynolds G. A., Bowers C. Y. and Badger T. M. (1995) Diagnostic studies with intravenous and intranasal growth hormone releasing peptide-2 in children of short stature. J. Clin. Endocrinol. Metab. 80: 2987-2992
56. Van den Berghe G., de Zegher F., Bowers C. Y., Wouters P., Muller P., Soetens F. et al. (1996) Pituitary responsiveness to growth hormone (GH)-releasing hormone, GH-releasing peptide-2 (GHRP-2) and thyrotropin-releasing hormone in critical illness. Clin. Endocrinol. 45: 341-351
57. Van den Berghe G., de Zegher F., Veldhuis J. D., Wouters P., Awouters M., Verbruggen W. et al. (1997) The somatotropic axis in critical illness: effect of continuous GHRH and GHRP-2 infusion. J. Clin. Endocrinol. Metab. 82: 590-599
58. Van den Berghe G., De Zegher F., Baxter R. C., Veldhuis J. D., Wouters P., Schetz M. et al. (1998) Neuroendocrinology of prolonged critical illness: effects of exogenous thyrotropin-releasing hormone and its combination with growth hormone-secretagogues. J. Clin. Endocrinol. Metab. 83: 309-319
59. Cordido F., Penalva A., Dieguez C. and Casanueva F. F. (1993) Massive growth hormone discharge after combined administration of GHRH and GHRP-6: evidence for a marked somatotroph secretory capability in obestiy. J. Clin. Endocrinol. Metab. 76: 819-823
60. Popovic V., Micic D., Djurovic M., Obradovic S., Casanueva F. F. and Dieguez C. (1997) Absence of desensitization by hexarelin to subsequent GH releasing hormone-mediated GH secretion in patients with anorexia nervosa. Clin. Endocrinol. 46: 539-543
61. Ghigo E., Arvat E., Muccioli G. and Camanni F. (1997) Growth hormone releasing peptides. Eur. J. Endocrinol. 136: 445-460
62. Ghigo E., Arvat E., Ramunni J., Colao A., Gianotti L., Deghenghi R. et al. (1997) Adrenocroticotropin and cortisol releasing effect of hexarelin, a synthetic growth hormone releasing peptide, in normal subjects and patients with Cushing's syndrome. J. Clin. Endocrinol. Metab. 82: 2439-2444